These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7181659)

  • 21. Diffuse fasciculations induced by D-penicillamine.
    Pinals RS
    J Rheumatol; 1983 Oct; 10(5):809-10. PubMed ID: 6644706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pemphigus folliaceous following D-penicillamine in rheumatoid arthritis].
    Brenner S; Caspi D; Tchetchik R; Krakowski A; Yaron M
    Harefuah; 1983 Feb; 104(3):94-6. PubMed ID: 6618302
    [No Abstract]   [Full Text] [Related]  

  • 23. [Myasthenia gravis pseudoparalytica as a result of penicillamine treatment of rheumatoid arthritis].
    Gietka A
    Reumatologia; 1982; 20(1-2):65-8. PubMed ID: 7163666
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of common rheumatoid polyarthritis with D-penicillamine].
    Camus JP; Bénichou C; Guillien P; Crouzet J; Lièvre JA
    Rev Rhum Mal Osteoartic; 1971 Dec; 38(12):809-20. PubMed ID: 5152714
    [No Abstract]   [Full Text] [Related]  

  • 25. D-penicillamine and the ocular myasthenic syndrome.
    Kimbrough RL; Mewis L; Stewart RH
    Ann Ophthalmol; 1981 Oct; 13(10):1171-2. PubMed ID: 7316342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rheumatoid arthritis, obliterating bronchiolitis and D-penicillamine. Apropos of a new case with ultrastructural examination and review of the literature].
    Geraads A; Brambilla E; Hohn B; Piton JL; Blanc-Jouvan F; Kamel A
    Poumon Coeur; 1983; 39(5):257-62. PubMed ID: 6657554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunologic abnormalities during treatment with penicillamine].
    Recordier AM; Roux H; Mercier P; Maestracci D; Schiano A
    Ann Med Interne (Paris); 1976 AUG-SEP; 127(8-9):566-70. PubMed ID: 64126
    [No Abstract]   [Full Text] [Related]  

  • 28. [D-penicillamine induced myasthenic syndromes in rheumatoid arthritis. Two cases (author's transl)].
    Rodat O; Hamelin JP; Rossard A; Cottin S; Cler JM; Rodat G; Lemouroux P
    Nouv Presse Med; 1981 May; 10(20):1645-8. PubMed ID: 7255126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fatal medullary aplasia after administration of D penicillamine for rheumatoid arthritis].
    Aymard JP; Baille N; Witz F; Colomb JN; Lederlin P
    Nouv Presse Med; 1980 Sep; 9(32):2255-6. PubMed ID: 7422520
    [No Abstract]   [Full Text] [Related]  

  • 30. [Minimal lesion nephrotic syndrome following treatment with D-penicillamine].
    González C; Romero R; Requeséns C; Nogues R; Oliver A; Carreras M; Mauri J
    Rev Clin Esp; 1982 Feb; 164(3):207-9. PubMed ID: 7089341
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparative study of the efficacy of 2 different doses of D-penicillamine in rheumatoid arthritis].
    Agababova E; Sidel'nikova S; Aseeva E; Nikol'skaia N; Gaziian R
    Ter Arkh; 1981; 53(7):62-7. PubMed ID: 6457408
    [No Abstract]   [Full Text] [Related]  

  • 32. [Minimal changes nephrotic syndrome associated to penicillamine treatment].
    Basterrechea MA; de Arriba G; García-Martín F; Sánchez-Heras M; Giménez-Vega E; Sánchez J
    Nefrologia; 2004; 24(2):183-7. PubMed ID: 15219094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long-term treatment of chronic progredient polyarthritis with D-penicillamine].
    Hagemann D; Frankl R
    Med Welt; 1969 Aug; 35():1920-3. PubMed ID: 5809869
    [No Abstract]   [Full Text] [Related]  

  • 34. [Extramembranous glomerulonephritis induced by D-penicillamine. Description of a case].
    Miguel Donderis A; Sánchez Vegazo I; Gómez Campdera FJ; Gallego JL; Fernández Fernández J; Sanz Guajardo D; Botella J
    Rev Clin Esp; 1981 Jan; 160(2):137-8. PubMed ID: 7209061
    [No Abstract]   [Full Text] [Related]  

  • 35. [Basic therapy of rheumatoid arthritis with D-penicillamine. Personal contribution and critical observations].
    Gigante D; Teodori S; Crispo M
    Fortschr Med; 1983 Apr; 101(13):613-8. PubMed ID: 6852728
    [No Abstract]   [Full Text] [Related]  

  • 36. [A case of agranulocytosis which occurred several hours after the readministration of D-penicillamine accompanied by shivering-chillness].
    Negishi M; Matsuda A; Kaga S; Kanemitsu H; Hashimoto M; Kobayashi K; Ide H
    Arerugi; 1995 Feb; 44(2):96-9. PubMed ID: 7726755
    [No Abstract]   [Full Text] [Related]  

  • 37. [D-penicillamine-induced myasthenia gravis].
    Frey RA; Keller F; Michel BA
    Schweiz Med Wochenschr; 1994 May; 124(20):852-6. PubMed ID: 8209208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Agranulocytosis and myasthenia gravis probably induced by D-penicillamine in rheumatoid patients (author's transl)].
    Hoshi K; Mizushima Y
    Ryumachi; 1981 May; 21(3):234-42. PubMed ID: 7313901
    [No Abstract]   [Full Text] [Related]  

  • 39. [Myasthenia caused by D-penicillamine in rheumatoid arthritis].
    Héraud A; Dromer C; Fatout E; Fournié B; Fournié A
    Rev Rhum Ed Fr; 1994 Jan; 61(1):59-60. PubMed ID: 8000404
    [No Abstract]   [Full Text] [Related]  

  • 40. Penicillamine-induced myositis in rheumatoid arthritis.
    Morgan GJ; McGuire JL; Ochoa J
    Muscle Nerve; 1981; 4(2):137-40. PubMed ID: 7207503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.